Meldonium and MK-2866 Interaction
Meldonium and MK-2866 have an interaction requiring monitoring for interaction with 47% confidence. Both Meldonium and MK-2866 negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Both compounds affect the heart, so monitoring these systems is recommended.
Compound Profiles
Meldonium
Metabolic Modulator | Endurance & Cardioprotection
Meldonium exerts its primary pharmacological effect by inhibiting gamma-butyrobetaine hydroxylase (BBOX), the enzyme responsible for the final step in the biosynthesis of L-carnitine from gamma-butyrobetaine (GBB). By competitively blocking this enzyme, meldonium reduces endogenous carnitine production, which in turn lowers intracellular carnitine concentrations over time.
View full profileMK-2866
Selective Androgen Receptor Modulator | Muscle Wasting Research
MK-2866 binds to the androgen receptor (AR) with high affinity and selectivity, functioning as a partial agonist in muscle and bone tissue. Upon binding, the MK-2866-AR complex undergoes a conformational change that promotes nuclear translocation and interaction with androgen response elements (AREs) on DNA, activating transcription of genes involved in protein synthesis, nitrogen retention, and myogenic differentiation.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Meldonium with MK-2866?
Yes, but with caution. Both Meldonium and MK-2866 negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Regular monitoring is advised.
Is Meldonium and MK-2866 safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: lipid disrupting. Monitor accordingly.
What are the interactions between Meldonium and MK-2866?
Both Meldonium and MK-2866 negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Meldonium and MK-2866?
Meldonium has a half-life of ~4-6 hours and MK-2866 has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.